Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphismEmiko Sugiyama, Nahoko Kaniwa, Su-Ryang Kim, et al.
Pharmacogenetics and Genomics|June 15, 2007
Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28Hironobu Minami, Kimie Sai, Mayumi Saeki, et al.
Molecular & Cellular Proteomics : MCP|January 12, 2010
Survival prediction for pancreatic cancer patients receiving gemcitabine treatmentJunichi Matsubara, Masaya Ono, Kazufumi Honda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatinKan Yonemori, Hideki Ueno, Takuji Okusaka, et al.
Drug Metabolism and Pharmacokinetics|November 19, 2010
Genetic polymorphisms and haplotypes of por, encoding cytochrome p450 oxidoreductase, in a Japanese populationYoshiro Saito, Noboru Yamamoto, Noriko Katori, et al.
Drug Metabolism and Pharmacokinetics|July 22, 2006
Thirty novel genetic variations in the SLC29A1 gene encoding human equilibrative nucleoside transporter 1 (hENT1)Su-Ryang Kim, Yoshiro Saito, Keiko Maekawa, et al.
Drug Metabolism and Pharmacokinetics|May 17, 2006
Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese populationKeiko Maekawa, Masaya Itoda, Kimie Sai, et al.
Pageof 7